Is Vaxart Stock a Buy? [The Motley Fool]
Vaxart, Inc. (VXRT)
Last vaxart, inc. earnings: 3/19 04:01 pm
Check Earnings Report
Company Research
Source: The Motley Fool
Vaxart(NASDAQ:VXRTVaxart's stock could see even better days ahead if it manages to develop a vaccine for COVID-9. The biotech also has at least one non-COVID-9 program worth mentioning. On the flip side, though, investors have to consider the genuine possibility that its coronavirus vaccine efforts will flop, and the stock will lose much of its gains as a result. With this backdrop in mind, should investors be jumping on the Vaxart bandwagon, or is it best to avoid the company's shares?Vaxart's potential COVID-9 vaccineIn late March, Vaxart announced that it had developed five potential oral COVID-9 vaccines, and the company went on to initiate pre-clinical trials for these candidates. These pre-clinical tests went well, with several of the vaccine candidates generating immune responses in "all tested animal models after a single dose," the company said.Image source: Getty Images.In May, Vaxart selected the vaccine that it said had the best chance of generating "the broadest immune re
Show less
Read more
Impact Snapshot
Event Time:
VXRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VXRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VXRT alerts
High impacting Vaxart, Inc. news events
Weekly update
A roundup of the hottest topics
VXRT
News
- Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13GlobeNewswire
- Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers [Yahoo! Finance]Yahoo! Finance
- Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersGlobeNewswire
- Vaxart to Present at World Vaccine Congress Washington 2024 on April 3GlobeNewswire
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
VXRT
Earnings
- 11/2/23 - Beat
VXRT
Sec Filings
- 4/30/24 - Form 8-K
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- VXRT's page on the SEC website